GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » EV-to-EBITDA

RIV Capital (XCNQ:RIV) EV-to-EBITDA : -1.26 (As of Apr. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, RIV Capital's enterprise value is C$59.62 Mil. RIV Capital's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was C$-47.24 Mil. Therefore, RIV Capital's EV-to-EBITDA for today is -1.26.

The historical rank and industry rank for RIV Capital's EV-to-EBITDA or its related term are showing as below:

XCNQ:RIV' s EV-to-EBITDA Range Over the Past 10 Years
Min: -5.69   Med: -0.05   Max: 24.81
Current: -1.27

During the past 6 years, the highest EV-to-EBITDA of RIV Capital was 24.81. The lowest was -5.69. And the median was -0.05.

XCNQ:RIV's EV-to-EBITDA is ranked worse than
100% of 707 companies
in the Drug Manufacturers industry
Industry Median: 14.03 vs XCNQ:RIV: -1.27

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), RIV Capital's stock price is C$0.105. RIV Capital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.462. Therefore, RIV Capital's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


RIV Capital EV-to-EBITDA Historical Data

The historical data trend for RIV Capital's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital EV-to-EBITDA Chart

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial 71.69 -3.14 -1.34 -1.48 -0.15

RIV Capital Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.05 -0.15 -0.22 -1.47

Competitive Comparison of RIV Capital's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RIV Capital's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where RIV Capital's EV-to-EBITDA falls into.



RIV Capital EV-to-EBITDA Calculation

RIV Capital's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=59.617/-47.239
=-1.26

RIV Capital's current Enterprise Value is C$59.62 Mil.
RIV Capital's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-47.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RIV Capital  (XCNQ:RIV) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

RIV Capital's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.105/-0.462
=At Loss

RIV Capital's share price for today is C$0.105.
RIV Capital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.462.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


RIV Capital EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of RIV Capital's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital (XCNQ:RIV) Business Description

Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.